ES2042818T3 - Agente terapeutico para la trombocitopenia. - Google Patents

Agente terapeutico para la trombocitopenia.

Info

Publication number
ES2042818T3
ES2042818T3 ES89102324T ES89102324T ES2042818T3 ES 2042818 T3 ES2042818 T3 ES 2042818T3 ES 89102324 T ES89102324 T ES 89102324T ES 89102324 T ES89102324 T ES 89102324T ES 2042818 T3 ES2042818 T3 ES 2042818T3
Authority
ES
Spain
Prior art keywords
thrombocitopenia
therapeutic agent
monocytemaciophagus
hematopeyetic
colonies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89102324T
Other languages
English (en)
Inventor
Fumimaro Takaku
Kazuo Motoyoshi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morinaga Milk Industry Co Ltd
Tanabe Pharma Corp
GC Biopharma Corp
Original Assignee
Green Cross Corp Japan
Morinaga Milk Industry Co Ltd
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan, Morinaga Milk Industry Co Ltd, Green Cross Corp Korea filed Critical Green Cross Corp Japan
Application granted granted Critical
Publication of ES2042818T3 publication Critical patent/ES2042818T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/243—Colony Stimulating Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

UN AGENTE TERAPEUTICO PARA LA TROMBOCITOPENIA DEBIDA A ENFERMEDADES HEMATOPEYETICAS ORIGINADAS POR VARIAS CAUSAS COMPRENDE COMO INGREDIENTE ACTIVO UN FACTOR ESTIMULANTE DE COLONIAS DE MONOCITEMACIOFAGOS ESPECIFICOS HUMANOS. SE ADMINISTRA PARA EL TRATAMIENTPO Y/O PREVENCION DE CADA TROMBOCITOPENIA.
ES89102324T 1988-02-10 1989-02-10 Agente terapeutico para la trombocitopenia. Expired - Lifetime ES2042818T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63029819A JPH0611705B2 (ja) 1988-02-10 1988-02-10 血小板減少症治療剤

Publications (1)

Publication Number Publication Date
ES2042818T3 true ES2042818T3 (es) 1993-12-16

Family

ID=12286632

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89102324T Expired - Lifetime ES2042818T3 (es) 1988-02-10 1989-02-10 Agente terapeutico para la trombocitopenia.

Country Status (7)

Country Link
US (1) US5114710A (es)
EP (1) EP0328132B1 (es)
JP (1) JPH0611705B2 (es)
KR (1) KR970009890B1 (es)
CA (1) CA1332149C (es)
DE (1) DE68907933T2 (es)
ES (1) ES2042818T3 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888495A (en) * 1988-05-23 1999-03-30 Genetics Institute, Inc. Method of producing storage stable M-CSF lyophilizates
JPH07103041B2 (ja) * 1989-04-04 1995-11-08 森永乳業株式会社 悪性腫瘍治療補助剤
US5714140A (en) * 1989-12-13 1998-02-03 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting the production of bioactive IL-1 by administering M-CSF
US5554512A (en) * 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
US7294331B2 (en) * 1994-03-07 2007-11-13 Immunex Corporation Methods of using flt3-ligand in hematopoietic cell transplantation
US7150992B1 (en) 1995-10-04 2006-12-19 Innunex Corporation Methods of preparing dendritic cells with flt3-ligand and antigen
US20020034517A1 (en) * 1995-10-04 2002-03-21 Kenneth Brasel Dendritic cell stimulatory factor
US7361330B2 (en) 1995-10-04 2008-04-22 Immunex Corporation Methods of using flt3-ligand in the treatment of fibrosarcoma

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6030291B2 (ja) * 1978-03-20 1985-07-16 森永乳業株式会社 人顆粒球の分化増殖を促進するｈｇｉ糖蛋白質、ｈｇｉ糖蛋白質の製造法及びｈｇｉ糖蛋白質を含有する白血球減少症治療剤
US4230697A (en) * 1978-07-03 1980-10-28 Morinaga Milk Industry Co. Ltd. Virus-inactivated HGI-glycoprotein capable of stimulating proliferation and differentiation of human granulocyte, process for preparing same and leukopenia curative containing same
DE3686794T2 (de) * 1985-02-05 1993-03-04 Cetus Oncology Corp Reinigung des natuerlichen kolonie-stimulierenden faktors-1.
JPH0753667B2 (ja) * 1985-08-09 1995-06-07 新技術開発事業団 骨髄移植療法補助剤
DE3777623D1 (de) * 1986-12-07 1992-04-23 Morinaga Milk Industry Co Ltd Kolonie-stimulierender faktor und verfahren zu seiner herstellung.

Also Published As

Publication number Publication date
DE68907933T2 (de) 1993-12-16
KR890012664A (ko) 1989-09-18
US5114710A (en) 1992-05-19
JPH0611705B2 (ja) 1994-02-16
EP0328132B1 (en) 1993-08-04
CA1332149C (en) 1994-09-27
DE68907933D1 (en) 1993-09-09
JPH01207244A (ja) 1989-08-21
EP0328132A3 (en) 1990-04-18
KR970009890B1 (ko) 1997-06-19
EP0328132A2 (en) 1989-08-16

Similar Documents

Publication Publication Date Title
ATE410506T1 (de) Behandlung der pompeschen krankheit
NO20034684D0 (no) Innretning for administrering av midler gjennom stratum corcum
ATE51342T1 (de) Mittel und vorrichtung zur steuerung der transdermalen penetration topischer und systematischer wirkstoffe.
EP1064000A4 (en) VITAMIN D AND ITS ANALOGS FOR THE TREATMENT OF TUMORS AND OTHER HYPERPROLIFERATION DISORDERS
NO920051D0 (no) Farmasoeytisk sammensetning for slanking
ATE302003T1 (de) Zubereitungen enthaltend apomorphin und sildenafil und ihre verwendung zur behandlung von erektiler dysfunktion
JPS57212114A (en) Capsule containing allergen activator and preparation therefor
ATE62414T1 (de) Mittel zur behandlung von herzerkrankungen.
DE60003837D1 (de) Tetrapeptid, das die funktionelle aktivität von neuronen stimuliert, dieses enthaltendes pharmakologisches mittel und seine verwendung
ES2191329T3 (es) Utilizacion de xantofilos en medicamentos para la mejora de la duracion de la funcion muscular o el tratamiento de trastornos o enfermedades musculares.
NZ517038A (en) Use of serotonin reuptake inihibitor in medicaments for treating sexual dysfunction
DE60018409D1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
ES2143467T3 (es) Agente terapeutico para el tratamiento de las heridas.
ES2138602T3 (es) Agente terapeutico para la amenaza de aborto.
ES2106319T3 (es) Uso de lactoferrina en la fabricacion de un medicamento para el tratamiento del reumatismo.
KR900007434A (ko) 시스타틴을 유효 성분으로하는 치료제
US4474759A (en) Method of treating bacterial, viral or parasitic diseases
AR003979A1 (es) Administracion transdermica de vorozol.
ES2192810T3 (es) Empleo de monoxidina como medicamento de actividad estimulante de la termogenesis.
FR2437832A1 (fr) Medicament a base de p-tolyl diiodomethylsulfone utile notamment pour le traitement des infections cutanees provoquees par les levures et les champignons
EE200200549A (et) Jagatud doosi teraapia veresooni kahjustava aktiivsusega
FR2786699B1 (fr) Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles
DK277387A (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
RU94000695A (ru) Средство с противоаллергическим действием
ES2031930T3 (es) Un metodo para obtener una preparacion liofilizada que contiene aspoxicilina como ingrediente activo.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 328132

Country of ref document: ES